Toward a Safe and Reachable Preventive Therapy for LTBI: a Multicenter Randomized Controlled Study in Taiwan

Trial Profile

Toward a Safe and Reachable Preventive Therapy for LTBI: a Multicenter Randomized Controlled Study in Taiwan

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 20 Dec 2016

At a glance

  • Drugs Rifapentine (Primary) ; Isoniazid
  • Indications Tuberculosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Dec 2016 Status changed from recruiting to active, no longer recruiting.
    • 30 Oct 2015 Planned number of patients changed from 363 to 322, according to ClinicalTrials.gov record.
    • 16 Mar 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top